Evidence map›Paper›PMID 37053213›Full record

ArticlePloS one2023

Tailoring baker's yeast Saccharomyces cerevisiae for functional testing of channelrhodopsin.

Sebastian Höler, Daniel Degreif, Florentine Stix, Shang Yang, Shiqiang Gao, Georg Nagel, Anna Moroni, Gerhard Thiel, Adam Bertl, Oliver Rauh

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sebastian HölerDepartment of Biology, Technische Universität Darmstadt, Darmstadt, Germany.
Daniel DegreifDepartment of Biology, Technische Universität Darmstadt, Darmstadt, Germany.
Florentine StixDepartment of Biology, Technische Universität Darmstadt, Darmstadt, Germany.
Shang YangInstitute of Physiology-Neurophysiology, Biocentre, Julius-Maximilians-University, Wuerzburg, Germany.
Shiqiang GaoInstitute of Physiology-Neurophysiology, Biocentre, Julius-Maximilians-University, Wuerzburg, Germany.ORCID 0000-0001-6190-9443
Georg NagelInstitute of Physiology-Neurophysiology, Biocentre, Julius-Maximilians-University, Wuerzburg, Germany.ORCID 0000-0001-8174-8712
Anna MoroniDepartment of Biosciences and CNR IBF-Mi, Università degli Studi di Milano, Milano, Italy.
Gerhard ThielDepartment of Biology, Technische Universität Darmstadt, Darmstadt, Germany.ORCID 0000-0002-2335-1351
Adam BertlDepartment of Biology, Technische Universität Darmstadt, Darmstadt, Germany.
Oliver RauhDepartment of Biology, Technische Universität Darmstadt, Darmstadt, Germany.
Technische Universität Darmstadt · DEUniversity of Würzburg · DEUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Channelrhodopsin 2 (ChR2) and its variants are the most frequent tools for remote manipulation of electrical properties in cells via light. Ongoing attempts try to enlarge their functional spectrum with respect to ion selectivity, light sensitivity and protein trafficking by mutations, protein engineering and environmental mining of ChR2 variants. A shortcoming in the required functional testing of large numbers of ChR2 variants is the lack of an easy screening system. Baker's yeast, which was successfully employed for testing ion channels from eukaryotes has not yet been used for screening of ChR2s, because they neither produce the retinal chromophore nor its precursor carotenoids. We found that addition of retinal to the external medium was not sufficient for detecting robust ChR activity in yeast in simple growth assays. This obstacle was overcome by metabolic engineering of a yeast strain, which constitutively produces retinal. In proof of concept experiments we functionally express different ChR variants in these cells and monitor their blue light induced activity in simple growth assays. We find that light activation of ChR augments an influx of Na+ with a consequent inhibition of cell growth. In a K+ uptake deficient yeast strain, growth can be rescued in selective medium by the blue light induced K+ conductance of ChR. This yeast strain can now be used as chassis for screening of new functional ChR variants and mutant libraries in simple yeast growth assays under defined selective conditions.

Indexed as

Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsChannelrhodopsinsFermentationMetabolic EngineeringMutationChannelrhodopsinsSaccharomyces cerevisiae Proteins

Identifiers

PMID37053213
PMCPMC10101416
OpenAlexW4365443475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.